NCT06104904 Managing Anxiety in Pediatric Primary Care (MAPP)
| NCT ID | NCT06104904 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UConn Health |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-11-20 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-11-20 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to conduct a randomized controlled trial to enhance the capacity of pediatric primary care providers to assist their patients who struggle with anxiety. The study aims to refine and assess the feasibility of the Anxiety Action Plan (AxAP), a brief intervention to reduce pediatric anxiety, delivered by primary care providers (PCPs) in community pediatric primary care clinics. The goal of the AxAP is to enhance the capacity of PCPs to identify and intervene with anxious youth, which will enhance access to care in general and especially in locations with few mental health specialists. PCPs participating in this study will attend a training, administer the intervention to enrolled youth assigned to the MAPP condition, participate in coaching sessions, and fill out study questionnaires. Families participating in this study will complete evaluations with the study team, receive the intervention from their PCP (if assigned to the MAPP condition), and fill out study questionnaires. Researchers will compare the MAPP intervention to Enhanced Usual Care (EUC; consisting of videos, handouts, and other resources for anxiety reduction) to see the differences, if any, in child outcomes.
Eligibility Criteria
Inclusion Criteria for youth: * 6-17 years of age * Have elevated anxiety symptoms as indicated by a total Screen for Child Anxiety Rated Disorders score between 20 and 55 based on parent and/or child report Exclusion Criteria for youth: * Have a medical or psychiatric condition contraindicating participation (e.g., suicidality) based on clinical interview * Are receiving psychosocial mental health treatment for anxiety Inclusion Criteria for PCPs: * PCPs must have a PA, RN, NP, APRN or MD degree and be at least a part time employee in a primary care setting. There are no other inclusion/exclusion criteria.
Contact & Investigator
Golda S Ginsburg, PhD
PRINCIPAL INVESTIGATOR
UConn Health
Frequently Asked Questions
Who can join the NCT06104904 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06104904 currently recruiting?
Yes, NCT06104904 is actively recruiting participants. Contact the research team at gginsburg@uchc.edu for enrollment information.
Where is the NCT06104904 trial being conducted?
This trial is being conducted at West Hartford, United States.
Who is sponsoring the NCT06104904 clinical trial?
NCT06104904 is sponsored by UConn Health. The principal investigator is Golda S Ginsburg, PhD at UConn Health. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.